Pharma Business Line

Singapore Stock Exchange set to stop the bleeding on Thursday

(RTTNews) – Singapore’s stock market has fallen over consecutive trading days, losing nearly 10 points or 0.3% along the way. The Straits Times Index now sits just above the 3,225 point plateau, although it is expected to gain ground on Thursday. Global forecasts for Asian markets are stable to higher …

Read More »

Automatic factory for NC? Site recruiter says state is ready to be a player

RALEIGH – Whether North Carolina becomes home to a huge battery factory today or in the near future, the state is a candidate for future electric vehicle manufacturing. That’s what a well-known industrial site recruiter says. The state’s economic investment committee is due to meet today as discussions circulate on …

Read More »

Yeh from PharmaEngine, first female winner at ITRI

Founder of PharmaEngine Inc (智 擎 生 技) Grace Yeh (葉常菁) became the first female Fellow of the Industrial Technology Research Institute (ITRI, 工業 技術 研究院) since it began awarding scholarships to business leaders 10 years ago. ITRI ​​President Lee Chih-kung (李世光) said at the 10th ITRI Laureates Awards Ceremony …

Read More »

Strong Medication Needed To Get Protocol Through Before Christmas – Slugger O’Toole

The pace of Protocol negotiations is accelerating. Yesterday and earlier today, the BBC gave rare importance to this incomprehensible nationally (if you are not NI / Irish) topic. After today’s meeting the straws in the wind were a little more favorable but without Lord Frost clearly changing his position. Technical …

Read More »

Gilead pays to retain rights to Arcus cancer drugs

Dive brief: Gilead will pay $ 725 million to retain the rights to four experimental cancer immunotherapies developed by Arcus Biosciences, Thursday announcement that it would confirm an option agreement the two companies signed in 2020. The most advanced projects involved are aimed at a cellular target called TIGIT which …

Read More »

What does the J&J split mean for the medical device industry?

Wall Street analysts say Johnson & Johnson’s recent decision to split the consumer health unit into its own company is likely to spur growth and increase operating margins for the remaining segments of pharmaceuticals and medical devices. The health giant’s low-growth consumer health brands are a drag for pharmaceutical and …

Read More »